John H Johnson is a notable inventor based in Kirkwood, MO (US), recognized for his significant contributions to the field of blood coagulation. With a total of 13 patents to his name, Johnson has made remarkable advancements that have the potential to improve medical treatments and patient outcomes.

Latest Patents

Among his latest patents, Johnson has developed a method for creating a heparin polyelectrolyte polymer complex. This innovation allows for the high-yield fractionation of blood plasma to obtain a concentrate of blood coagulation Factor VIII:C. The process involves a sequence of adsorption steps using two different water-insoluble, cross-linked polyelectrolyte copolymers, each utilized in the presence of exogenous heparin. Additionally, he has patented a similar method for the production of blood coagulation factor VIII:C, further emphasizing his expertise in this critical area of medical technology.

Career Highlights

Johnson is currently associated with Monsanto Company, where he applies his innovative skills to develop solutions that address complex medical challenges. His work has not only contributed to the advancement of medical science but has also positioned him as a key figure in the industry.

Collaborations

Throughout his career, Johnson has collaborated with esteemed colleagues such as Joseph E Fields and Lloyd E Weeks. These partnerships have fostered an environment of innovation and have led to the successful development of various technologies in the field of blood coagulation.

Conclusion

John H Johnson's contributions to blood coagulation technologies through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements that can enhance patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com